BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2975107)

  • 1. Suggested mode of action of D-penicillamine as an immunosuppressive agent in rheumatoid arthritis.
    Lipsky PE
    Z Rheumatol; 1988; 47 Suppl 1():6-8. PubMed ID: 2975107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppression by D-penicillamine in vitro. Inhibition of human T lymphocyte proliferation by copper- or ceruloplasmin-dependent generation of hydrogen peroxide and protection by monocytes.
    Lipsky PE
    J Clin Invest; 1984 Jan; 73(1):53-65. PubMed ID: 6606652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro production and scavenging of hydrogen peroxide by D-penicillamine. Relationship to copper availability.
    Staite ND; Messner RP; Zoschke DC
    Arthritis Rheum; 1985 Aug; 28(8):914-21. PubMed ID: 4026887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [D-penicillamine: mechanism of cellular action and induced autoimmune diseases].
    Meyer O
    Rev Rhum Mal Osteoartic; 1986 Jan; 53(1):15-20. PubMed ID: 2939541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D-Penicillamine: analysis of the mechanism of copper-catalyzed hydrogen peroxide generation.
    Starkebaum G; Root RK
    J Immunol; 1985 May; 134(5):3371-8. PubMed ID: 2984288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of human antibody production in vitro by D-penicillamine and CuSO4: inhibition of helper T cell function.
    Lipsky PE
    J Rheumatol Suppl; 1981; 7():69-73. PubMed ID: 6971939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B lymphocyte function in patients with rheumatoid arthritis: impact of regulatory T lymphocytes and macrophages--modulation by antirheumatic drugs.
    Petersen J
    Dan Med Bull; 1988 Apr; 35(2):140-57. PubMed ID: 3282810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. D-penicillamine cooperates with copper sulfate to enhance the surface expression of functional Fas antigen in rheumatoid synovial fibroblasts via the generation of hydrogen peroxide.
    Harada S; Sugiyama E; Taki H; Shinoda K; Fujita T; Maruyama M; Kobayashi M
    Clin Exp Rheumatol; 2002; 20(4):469-76. PubMed ID: 12175101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of human endothelial cell proliferation in vitro and neovascularization in vivo by D-penicillamine.
    Matsubara T; Saura R; Hirohata K; Ziff M
    J Clin Invest; 1989 Jan; 83(1):158-67. PubMed ID: 2463265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of D-penicillamine on mitogen-induced human lymphocyte proliferation: synergistic inhibition by D-penicillamine and copper salts.
    Lipsky PE; Ziff M
    J Immunol; 1978 Mar; 120(3):1006-13. PubMed ID: 632576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An investigation into copper catalyzed D-penicillamine oxidation and subsequent hydrogen peroxide generation.
    Gupte A; Mumper RJ
    J Inorg Biochem; 2007 Apr; 101(4):594-602. PubMed ID: 17275091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of human helper T cell function in vitro by D-penicillamine and CuSO4.
    Lipsky PE; Ziff M
    J Clin Invest; 1980 May; 65(5):1069-76. PubMed ID: 6965944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Some immunological effects of penicillamine.
    Chen DM; Di Sabato G; Field L; Gallo AA; Harshman S
    Clin Exp Immunol; 1977 Nov; 30(2):317-22. PubMed ID: 304785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of D-penicillamine on lymphocyte modulation of synovial collagenase production.
    DeVore DP; Gruebel RJ; Hutson TB; Turner RH
    Agents Actions; 1979 Jun; 9(2):172-6. PubMed ID: 224682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of D-penicillamine on experimental allergic arthritis in rabbits].
    PĆ¼schel W; Rosenkranz M; Geiler G; Caffier B; Stiehl P; Richter V
    Z Rheumatol; 1976; 35(5-6):201-9. PubMed ID: 60013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helper T cell function of rheumatoid synovial tissue lymphocytes.
    McCain GA
    J Rheumatol; 1984 Aug; 11(4):438-47. PubMed ID: 6237204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disease-modifying agents in rheumatoid arthritis.
    Lipsky PE
    Ryumachi; 1987 Dec; 27(6):409-12. PubMed ID: 2455354
    [No Abstract]   [Full Text] [Related]  

  • 18. Bucillamine suppresses human Th1 cell development by a hydrogen peroxide-independent mechanism.
    Morinobu A; Wang Z; Kumagai S
    J Rheumatol; 2000 Apr; 27(4):851-8. PubMed ID: 10782806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The action of D-penicillamine on the distribution of T and B-lymphocytes in rheumatoid arthritis].
    Crouzet J; Fournier C; Bach JF; Camus JP
    Rev Rhum Mal Osteoartic; 1977 May; 44(5):335-7. PubMed ID: 329400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro immunosuppressive effect of 8-amino-9-benzylguanine on lymphocytes.
    Yen CY; Lin CY; Yu DS
    Transplant Proc; 1994 Aug; 26(4):1910-2. PubMed ID: 8066622
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.